Janssen's Tremfya Gains Psoriatic Arthritis Indication In EU
And BMS' Opdivo Gets Gastroesophageal Cancer OK
Executive Summary
The European Commission has extended the indications for Janssen’s Tremfya to include psoriatic arthritis, and those for BMS’s Opdivo to include gastroesophageal cancer.